4-[2-[1-[(4-fluorophenyl)methyl]-3-methyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-2-oxoethyl]cyclohexan-1-one;1-[(4-fluorophenyl)methyl]-3-methyl-4,5,6,7-tetrahydropyrazolo[5,4-c]pyridine;2-(4-oxocyclohexyl)acetic acid;hydrochloride
C44H55ClF2N6O5 — CID 159766821
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[2-[1-[(4-fluorophenyl)methyl]-3-methyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-2-oxoethyl]cyclohexan-1-one;1-[(4-fluorophenyl)methyl]-3-methyl-4,5,6,7-tetrahydropyrazolo[5,4-c]pyridine;2-(4-oxocyclohexyl)acetic acid;hydrochloride
4-[2-[1-[(4-fluorophenyl)methyl]-3-methyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-2-oxoethyl]cyclohexan-1-one;1-[(4-fluorophenyl)methyl]-3-methyl-4,5,6,7-tetrahydropyrazolo[5,4-c]pyridine;2-(4-oxocyclohexyl)acetic acid;hydrochloride (PubChem CID 159766821) has the molecular formula C44H55ClF2N6O5 and a molecular weight of 821.41 g/mol. Its IUPAC name is 4-[2-[1-[(4-fluorophenyl)methyl]-3-methyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-2-oxoethyl]cyclohexan-1-one;1-[(4-fluorophenyl)methyl]-3-methyl-4,5,6,7-tetrahydropyrazolo[5,4-c]pyridine;2-(4-oxocyclohexyl)acetic acid;hydrochloride.
Molecular Properties
| Compound Name | 4-[2-[1-[(4-fluorophenyl)methyl]-3-methyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-2-oxoethyl]cyclohexan-1-one;1-[(4-fluorophenyl)methyl]-3-methyl-4,5,6,7-tetrahydropyrazolo[5,4-c]pyridine;2-(4-oxocyclohexyl)acetic acid;hydrochloride |
|---|---|
| PubChem CID | 159766821 |
| Molecular Formula | C44H55ClF2N6O5 |
| Molecular Weight | 821.41 g/mol |
| Exact Mass | 820.39 |
| IUPAC Name | 4-[2-[1-[(4-fluorophenyl)methyl]-3-methyl-5,7-dihydro-4H-pyrazolo[5,4-c]pyridin-6-yl]-2-oxoethyl]cyclohexan-1-one;1-[(4-fluorophenyl)methyl]-3-methyl-4,5,6,7-tetrahydropyrazolo[5,4-c]pyridine;2-(4-oxocyclohexyl)acetic acid;hydrochloride |
| SMILES | Cc1nn(Cc2ccc(F)cc2)c2c1CCN(C(=O)CC1CCC(=O)CC1)C2.Cc1nn(Cc2ccc(F)cc2)c2c1CCNC2.Cl.O=C(O)CC1CCC(=O)CC1 |
| InChI | InChI=1S/C22H26FN3O2.C14H16FN3.C8H12O3.ClH/c1-15-20-10-11-25(22(28)12-16-4-8-19(27)9-5-16)14-21(20)26(24-15)13-17-2-6-18(23)7-3-17;1-10-13-6-7-16-8-14(13)18(17-10)9-11-2-4-12(15)5-3-11;9-7-3-1-6(2-4-7)5-8(10)11;/h2-3,6-7,16H,4-5,8-14H2,1H3;2-5,16H,6-9H2,1H3;6H,1-5H2,(H,10,11);1H |
| InChIKey | HUHPULBHNVJOGX-UHFFFAOYSA-N |
| XLogP | 7.08 |
| TPSA | 139.42 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 58 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 821.41 |
| LogP ≤ 5 | 7.08 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159766821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.